INS and metabolic dysfunction-associated steatotic liver disease: Insulin sensitivity impairment reduces the ability to suppress hepatic glucose production and insulin-stimulated glucose uptake in skeletal muscle, as well as increases fatty acid production from adipose tissue, ultimately resulting in a higher influx of fatty acids to the liver, consequently causing the emergence of NAFLD [30, 36–38].